UP!
| 2016-06-29 | Reiterated Rating | Brean Capital | Buy | |
| 2016-05-12 | Reiterated Rating | Brean Capital | Buy | |
| 2016-04-27 | Downgrade | First Analysis | Overweight to Equal Weight | $14.00 to $9.00 |
| 2016-04-19 | Lower Price Target | Lake Street Capital | Buy | $15.00 to $12.00 |
| 2016-04-11 | Lower Price Target | Needham & Company LLC | Strong-Buy | $13.00 to $12.00 |
| 2016-04-09 | Reiterated Rating | Brean Capital | Buy | |
| 2016-04-07 | Reiterated Rating | Needham & Company LLC | Strong-Buy | $13.00 to $12.00 |
| 2016-02-23 | Reiterated Rating | Needham & Company LLC | Buy | $13.00 |
| 2016-01-20 | Boost Price Target | First Analysis | Overweight | $11.00 to $15.00 |
| 2016-01-13 | Reiterated Rating | Canaccord Genuity | Buy | $12.00 |
| 2016-01-12 | Reiterated Rating | Needham & Company LLC | Buy | |
| 2016-01-12 | Reiterated Rating | Brean Capital | Positive to Buy | $12.00 |
| 2015-12-20 | Reiterated Rating | Needham & Company LLC | Buy | $13.00 |
| 2015-12-18 | Boost Price Target | Canaccord Genuity | $10.00 to $12.00 | |
| 2015-12-17 | Reiterated Rating | Brean Capital | Buy | $12.00 |
| 2015-12-17 | Reiterated Rating | Canaccord Genuity | Buy | $10.00 to $12.00 |
| 2015-11-16 | Upgrade | Needham & Company LLC | Buy to Strong-Buy | $13.00 |
| 2015-10-30 | Reiterated Rating | Brean Capital | Buy | $16.00 to $12.00 |
| 2015-10-30 | Upgrade | Northland Securities | Market Perform to Outperform | $10.00 |
| 2015-10-30 | Lower Price Target | Canaccord Genuity | Buy | $14.00 to $10.00 |
| 2015-10-30 | Reiterated Rating | Needham & Company LLC | Buy | $13.00 |
| 2015-10-15 | Reiterated Rating | Canaccord Genuity | Buy | $14.00 |
| 2015-10-13 | Reiterated Rating | Needham & Company LLC | Buy | $15.00 to $13.00 |
| 2015-09-02 | Reiterated Rating | Needham & Company LLC | Buy | $15.00 |
| 2015-08-24 | Reiterated Rating | Brean Capital | Buy | $16.00 |
| 2015-07-31 | Reiterated Rating | Brean Capital | Buy | $16.00 |
| 2015-07-30 | Reiterated Rating | Canaccord Genuity | Buy | $14.00 |
| 2015-07-29 | Downgrade | Needham & Company LLC | Strong-Buy to Buy | $15.00 |
| 2015-07-17 | Initiated Coverage | Brean Capital | Buy | $16.00 |
| 2015-07-09 | Initiated Coverage | First Analysis | Overweight | $14.00 |
| 2015-05-14 | Upgrade | Northland Securities | Under Perform to Market Perform | $7.00 to $10.00 |
| 2015-04-29 | Reiterated Rating | Canaccord Genuity | Buy | $14.00 |
| 2015-02-27 | Lower Price Target | Needham & Company LLC | Strong-Buy to Buy | $15.00 to $13.00 |
| 2015-02-20 | Upgrade | Needham & Company LLC | Buy to Strong-Buy | $16.00 to $13.00 |
| 2015-01-02 | Set Price Target | Needham & Company LLC | Buy | $13.00 |
| 2014-12-15 | Boost Price Target | Needham & Company LLC | Buy | $12.00 to $13.00 |
| 2014-11-18 | Boost Price Target | Needham & Company LLC | $12.00 | |
| 2014-10-30 | Boost Price Target | Needham & Company LLC | Buy | $9.50 to $11.00 |
| 2014-10-15 | Reiterated | Needham | Buy | $8.50 to $9.50 |
| 2014-10-15 | Reiterated Rating | Canaccord Genuity | Buy | $12.00 to $13.00 |
| 2014-10-15 | Boost Price Target | Needham & Company LLC | Buy | $8.50 to $9.50 |
| 2014-10-13 | Boost Price Target | Northland Securities | Market Perform | $6.00 to $6.50 |
| 2014-07-15 | Initiated | Needham | Buy | |
| 2014-07-15 | Initiated Coverage | Needham & Company LLC | Buy | $8.50 |
| 2014-01-06 | Downgrade | Northland Securities | Outperform to Market Perform | $6.00 |
| 2013-12-20 | Boost Price Target | Canaccord Genuity | $12.00 | |
| 2013-11-01 | Boost Price Target | Northland Securities | Outperform | $5.00 to $6.00 |
| 2013-10-31 | Boost Price Target | Canaccord Genuity | Buy | $6.00 to $6.50 |
| 2013-10-04 | Initiated Coverage | Canaccord Genuity | Buy | $6.00 |
| 2016-06-29 | Reiterated Rating | Brean Capital | Buy | |
| 2016-05-12 | Reiterated Rating | Brean Capital | Buy | |
| 2016-04-27 | Downgrade | First Analysis | Overweight to Equal Weight | $14.00 to $9.00 |
| 2016-04-19 | Lower Price Target | Lake Street Capital | Buy | $15.00 to $12.00 |
| 2016-04-11 | Lower Price Target | Needham & Company LLC | Strong-Buy | $13.00 to $12.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In MDXG 121 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Essex Woodlands Health Ventures, Inc. | 23.42M |
| BlackRock Fund Advisors | 7.80M |
| BlackRock Inc. | 7.60M |
| Vanguard Group, Inc | 6.02M |
| STATE STREET CORP | 3.85M |
| BlackRock Institutional Trust Company, N.A. | 2.74M |
| FEDERATED INVESTORS INC /PA/ | 2.55M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.05M |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1.14M |
| NORTHERN TRUST CORP | 1.00M |
| SCHWAB CHARLES INVESTMENT MANAGEMENT INC | 0.92M |
| RUSSELL FRANK CO/ | 0.72M |
| PARSONS CAPITAL MANAGEMENT INC/RI | 0.63M |
| PRUDENTIAL FINANCIAL INC | 0.62M |
| RENAISSANCE TECHNOLOGIES LLC | 0.56M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| PETIT PARKER H Chief Executive Officer | 4.32% (4567422) | INS / MDXG / |
| KOOB CHARLES E | 1.25% (1324459) | MDXG / |
| Eichler Kurt M | 0.63% (663406) | MDXG / |
| Taylor William Charles President and COO | 0.53% (557057) | MDXG / |
| GORLIN STEVE | 0.43% (451857) | COOL / DARA / MDXG / |
| Hack Bruce | 0.43% (450249) | MDXG / |
| Senken Michael J. Chief Financial Officer | 0.26% (273530) | MDXG / |
| MCCAW ROBERTA L General Counsel and Secretary | 0.18% (193247) | MDXG / |
| Haden Alexandra O General Counsel & Secretary | 0.16% (166994) | MDXG / |
| PAPASAN LARRY W | 0.14% (148042) | MDXG / |
| BLESER JOSEPH G | 0.12% (131545) | MDXG / |
| DEWBERRY J TERRY | 0.07% (77126) | MDXG / |
| YESTON NEIL | 0.07% (70460) | MDXG / |
| Evans Charles Robert | 0.06% (65460) | MDXG / |
| Aguilar Luis A | 0.02% (25333) | DFIN / ENV / MDXG / |
UM